Mild Cognitive Impairment (Psychology Press & Routledge Classic

In this review of Mild Cognitive Impairment (Psychology Press & Routledge Classic Editions) the bottom line is clear: this edition is essential for clinicians, researchers and graduate students who need a foundational, historically informed synthesis of MCI research and clinical debate. The reviewer found the new preface by Holly A. Tuokko particularly valuable because it frames how the field has evolved, highlights emerging intervention approaches, and links past diagnostic controversies to current work in early identification and intervention.

Key Features

• Historical synthesis: Brings together research from multiple studies and countries to map how the concept of mild cognitive impairment emerged and changed over time, useful for context in clinical decision making.
• New preface: Holly A. Tuokko provides an updated overview that evaluates growth in MCI research and practical implications for intervention and diagnosis.
• Intervention focus: Reviews pharmacological, cognitive and behavioral approaches so readers can compare evidence for early-stage strategies.
• Neuroplasticity perspective: Emphasizes lifespan neuroplasticity and the importance of early interventions, helping clinicians consider timing and targets for treatment.
• International perspectives: Includes contributions and data from various countries, supporting a broader view of diagnostic approaches and cross-cultural considerations.

Who It's For

This book suits neurologists, neuropsychologists, geriatric psychiatrists and graduate students who need a rigorous, research-driven account of MCI as the transitional state between normal aging and early Alzheimer-related decline. The updated preface makes it particularly helpful for practitioners wanting a contemporary synthesis alongside the original classic chapters.

Those looking for a quick clinical protocol, a handbook of step-by-step screening tools, or a fully updated textbook of the latest trials beyond the preface may want a more current clinical manual or systematic review focused solely on randomized controlled trials.

Pros & Cons

Pros

• Comprehensive historical and international synthesis helps place current MCI work in context.
• New preface by Holly A. Tuokko updates readers on growth in research and implications for practice.
• Balanced coverage of pharmacological, cognitive and behavioral interventions supports informed comparisons.

Cons

• As a Classic Edition with a preface, it does not replace a fully up-to-date clinical trial compendium for the most recent interventions.

Specifications

Our Verdict

This Classic Edition is a worthwhile purchase for clinicians and researchers who want a grounded, historically informed review of mild cognitive impairment and early intervention strategies. It adds contemporary context via the new preface and remains good value for readers seeking a thoughtful synthesis rather than a rapid trial update.

Frequently Asked Questions

Does this edition include new material?
The Classic Edition includes a new preface by Holly A. Tuokko that updates readers on developments in MCI research and intervention.

Is this book practical for clinicians?
Yes, it is practical as a research-informed reference to guide clinical thinking about diagnosis and intervention timing, though clinicians may supplement it with current trial reviews for the latest evidence.

Who are the primary authors?
Holly A. Tuokko and David F. Hultsch are credited, with the preface specifically from Tuokko providing the update.